首页> 外文期刊>Genes and Development: a Journal Devoted to the Molecular Analysis of Gene Expression in Eukaryotes, Prokaryotes, and Viruses >NF1 regulation of RAS/ERK signaling is required for appropriate granule neuron progenitor expansion and migration in cerebellar development
【24h】

NF1 regulation of RAS/ERK signaling is required for appropriate granule neuron progenitor expansion and migration in cerebellar development

机译:在小脑发育中适当的颗粒神经元祖细胞膨胀和迁移需要NF1 RAS / ERK信号传导

获取原文
获取原文并翻译 | 示例
           

摘要

Cerebellar development is regulated by a coordinated spatiotemporal interplay between granule neuron progenitors (GNPs), Purkinje neurons, and glia. Abnormal development can trigger motor deficits, and more recent data indicate important roles in aspects of memory, behavior, and autism spectrum disorders (ASDs). Germline mutation in the NF1 tumor suppressor gene underlies Neurofibromatosis type 1, a complex disease that enhances susceptibility to certain cancers and neurological disorders, including intellectual deficits and ASD. The NF1 gene encodes for neurofibromin, a RAS GTPase-activating protein, and thus negatively regulates the RAS signaling pathway. Here, using mousemodels to direct conditional NF1 ablation in either embryonic cerebellar progenitors or neonatal GNPs, we show that neurofibromin is required for appropriate development of cerebellar folia layering and structure. Remarkably, neonatal administration of inhibitors of the ERK pathway reversed the morphological defects. Thus, our findings establish a critical cell-autonomous role for the NF1–RAS–ERK pathway in the appropriate regulation of cerebellar development and provide a basis for using neonatal ERK inhibitor-based therapies to treat NF1-induced cerebellar disorders.
机译:小脑发展受颗粒神经元祖细胞(GNPS),Purkinje神经元和胶质胶之间的协调的时空相互作用。异常发育可以触发电机缺陷,更新的数据在记忆,行为和自闭症谱系统(ASDS)方面表示重要作用。 NF1肿瘤抑制基因的种系突变是神经纤维瘤病类型1,一种复杂的疾病,可增强对某些癌症和神经系统疾病的易感性,包括智力缺陷和ASD。 NF1基因对神经纤维素,RAS GTP酶活性蛋白质的编码,因此负调节RAS信号通路。在这里,使用Mousemodels在胚胎大脑祖细胞或新生儿GNP中直接有条件NF1消融,我们表明神经纤维蛋白是适当发展的小脑叶状糖分分层和结构。值得注意的是,ERK途径的新生儿抑制剂逆转了形态缺陷。因此,我们的研究结果在适当调节小脑发育的适当调节中为NF1-RAS-ERK途径建立了临界细胞 - 自主作用,并为使用新生儿ERK抑制剂的疗法提供基础以治疗NF1诱导的小脑障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号